Background
Description of the condition
Description of the intervention
How the intervention might work
Why it is important to do this study
Objective
Methods
Database and search strategy
Inclusion criteria
Exclusion criteria
Study selection
Data extraction and management
Assessment of quality of evidence in included studies
Data analysis
Results
Trial identification
Characteristics of included studies
a. Moxibustion vs. Western medications | ||||||
Included trials | Eligibility criteria | Interventions and treatment duration | Sample and characteristics (male female, age, disease duration) | Outcome Criteria (effective rate Criteria) | ||
Trial | Control | Trial | Control | |||
Wu 2014 [59] | CD&TETCMD&S | Moxibustion Duration:30d | Estazolam Duration:30d | 91; AGE: 20-75; Disease duration:3 m-30y | 91; AGE: 20-75; Disease duration:3 m-30y; | Unclear |
Wong 2014 [62] | CCMD-3 | Moxibustion Duration:20d | Estazolam Duration:20d | 40 (M: 18, F: 22); AGE: 18-63 (mean: 38); Disease duration: 1.5 m-4y | 40 (M: 16; F: 24); AGE: 18-66 (mean: 39); Disease duration:1.2 m-6y | GCTNPCM |
Yu 2012 [60] | -CCMD-3 -ICD10 | Moxibustion Duration:21d | Estazolam Duration: 14 d | 30; AGE: 13-65; Disease duration: 1 m-8 y | 30; AGE: 13-65; Disease duration:1 m-8y; | GCTNPCM |
Ju 2009 [54] | Sleep efficiency computation | Moxibustion Duration:10d | Estazolam Duration: 10 d | 40 (M: 18, F: 22); AGE: 25-75; Disease duration: 0.5y-5 y | 35 (M: 14 F: 21); AGE: 25-75; Disease duration:0.5y-5y | Sleep efficiency computation |
Yuan 2007 [61] | -CCMD-3 -ICD10 | Moxibustion Duration:20d | -Diazepam -Oryzanol --VB1
Duration: 20 d | 40; AGE 14-65; Disease duration: 1 m-10 y; | 40; AGE 14-65; Disease duration:1 m-10 y; | GCTNPCM |
b. Moxibustion vs. oral Chinese medicine | ||||||
Included trials | Eligibility criteria | Interventions and treatment duration | Sample and characteristics (male female, age, disease duration) | Outcome Criteria (effective rate Criteria) | ||
Trial | Control | Trial | Control | |||
Jiao 2015 [65] | -CCMD-3 -CDT&ETCMD&S | -Moxibustion -SanhuangAnshen Decoction Duration: 30d | SanhuangAnshen Decoction Duration: 30d | 80 (M: 37, F: 43); AGE: (mean: 67.8); Disease duration: -; | 79 (M: -, F: -); AGE: (mean: 65.1); Disease duration: -; | CDT&ETCMD&S |
Liu 2015 [66] | -CCMD-3 -GCTNPCM | Grain-moxibustion Duration: 14 d | Renshenguipi pill Duration: 14 d | 38; AGE: 18-70; Disease duration: -; | 38; AGE: 18-70; Disease duration: -; | GCTNPCM |
Zhang 2014 [68] | -CCMD-3 | -Moxibustion -Huatanjieyu decoction Duration: 10 d | Huatanjieyu decoction Duration: 7 d | 59; AGE: 34-65; Disease duration: -; | 59; AGE: 34-65; Disease duration: -; | Unclear |
He 2014 [63] | -ICD-10- -GCTNPCM | -Moxibustion -Tianwangbuxin decoction Duration: 32 d | Tianwangbuxin decoction Duration: 28 d | 30 (M: 12, F: 18); AGE:30-60 (mean:45.3 ± 4. 4); Disease duration: -; | 30 (M: 13, F: 17); AGE:31-60 (mean:46.2 ± 5.1); Disease duration: -; | GCTNPCM |
Wu 2010 [67] | -CCMD-3 -CDT&ETCMD&S | -Heat-sensitive Moxibustion –AnshenBunao decoction Duration: 22 d | AnshenBunao decoction Duration: 22 d | 30 (M: 13, F: 17); AGE:33-74 (mean:46.8); Disease duration: 1 w-2.7 y | 30 (M: 11, F: 19); AGE:35-75 (mean:45.7); Disease duration: 1w-2.5 y | GCTNPCM |
Hu 2007 [64] | PSQI | Moxibustion Duration: 30 d | AnshenBunao Ye Duration: 30 d | 30 (M: 12, F: 18); AGE: 19-65; Disease duration: 24 d-16 y | 30 (M: 14, F: 16); AGE: 18-67; Disease duration: 20 d-14 y | PSQI |
c. Moxibustion vs. other TCM therapies | ||||||
Included trials | Eligibility criteria | Interventions and treatment duration | Sample and characteristics (male female, age, disease duration) | Outcome Criteria (effective rate criteria) | ||
Trial | Control | Trial | Control | |||
Xie 2015 [77] | CCMD-3 | -Moxibustion -Head-acupoint massage Duration: 28 d | Head-acupoint massage Duration: 28 d | 30 (M: 17, F: 13); AGE: (mean: 43.3 ± 13.8 y); Disease duration: (mean: 11.5 ± 5.3 m); | 30 (M: 14, F: 16); AGE: (mean: 42.7 ± 12.4 y); Disease duration: (mean: 10.8 ± 4.7 m); | GCTNPCM |
Wang 2014 [76] | Unclear | -Moxibustion -Point-application Duration:15 d | Point-application Duration:15 d | 18 (M: 10, F: 8); AGE:39-65y (mean:45.2 y); Disease duration: - | 18 (M: 11, F: 7); AGE:41-69y (mean:48.1 y); Disease duration: - | Unclear |
Xu 2014 [78] | CD&TETCMD&S | -Heat-sensitive Moxibustion -Head-needle acupuncture Duration:24 d | Head-needle acupuncture Duration:24 d | 58 (M: -, F: -); AGE: 18-70 y; Disease duration: 12 m-60 m | 54 (M: -,F: -); AGE: 18-70 y; Disease duration: 12 m-60 m | sleep efficiency by international standard |
Shu 2014 [75] | GCTNPCM | -Moxibustion -Head-acupoint massage Duration:15 d | Head-acupoint massage Duration: 15 d | 9 (M: 0, F: 9); AGE: 30-56; Disease duration: 2 m-7 m | 9 (M: 0, F: 9); AGE: 30-56; Disease duration: 2 m-7 m | GCTNPCM |
Ma 2014 [73] | CCMD-3 | -Moxibustion -Auricular-plaster therapy Duration:47 d | Auricular-plaster therapy Duration:47 d | 99 (M: 38, F: 61); AGE: 20-64 y (mean: 38 ± 13 y); Disease duration: 0.5 y-20y (mean: 7.48 ± 4.57 y) | 96 (M: 33, F: 63); AGE: 21-62 y (mean: 37 ± 12 y); Disease duration: 0.5 y-20 y (mean: 7.13 ± 4.92 y) | unclear |
Li 2014 [70] | ICD-10 | -Moxibustion -Acupuncture Duration:21 d | -Acupuncture Duration:21 d | 35 (M: 12, F: 23); AGE: 20-60 y (mean: 45 ± 3. 5 y); Disease duration: 1 m-18 m (mean: 5.5 ± 4.2 m) | 35 (M: 8, F: 27); AGE: 25-60 (mean: 48 ± 4. 9 y); Disease duration: 1 m-18 m (mean: 5.6 ± 0.4 m) | GCTNPCM |
Quan 2012 [74] | CCMD-2-R | -Moxibustion -Acupuncture Duration:43 d | Acupuncture Duration:43 d | 36 (M: 15, F: 21); AGE: 19-67 y (mean:38.9 y); Disease duration: 6 m-9 y (mean: 5.3 y); | 36 (M: 17, F: 19); AGE: 20-68 y (mean:40.6 y); Disease duration: 5 m-10 y (mean: 5 y); | GCTNPCM |
Ao 2011 [69] | CCMD-3 | -Moxibustion -Acupuncture Duration:32-33 d | Acupuncture Duration:32-33d | 34 (M: 13, F: 21); AGE: (mean:40.54 ± 11.27); Disease duration: (mean: 9.7 ± 2.45 m); | 33 (M: 14, F: 19); AGE: (mean:39.67 ± 11.93); Disease duration: (mean: 8.47 ± 1.69 m); | Sleep efficiency by international standard |
Li 2011 [5] | CCMD-3 | -Moxibustion -Acupuncture Duration:28 d | Acupuncture Duration:28 d | 100 (M: 46, F: 54); AGE: (mean: 35.58 ± 9.87); Disease duration: (mean: 21.59 ± 7.87 m); | 98 (M: 45, F: 53); AGE: (mean: 36.67 ± 10.93); Disease duration:(mean: 22.76 ± 8.39 m); | GCTNPCM |
Chen 2010 [71] | -CCMD-3 -ICD -10 | -Moxibustion -Auricular-plaster therapy Duration:22-23 d | Auricular-plaster therapy Duration:22-23d | 37 (M: -,F: -); AGE:18-72 (mean:48); Disease duration: 2 m-7y | 26 (M: -,F: -); AGE:18-72 (mean:48); Disease duration: 2 m-7 y | Unclear |
Li 2010 [72] | -CCMD-2-R -CD&TETCMD&S | -Thunder-fire moxibustion -Acupuncture Duration:10-30 d | Acupuncture Duration:10-30d | 35 (M: 15, F: 20); AGE: (mean: 35.6); Disease duration: (mean: 3.3 y); | 35 (M: 16, F: 19); AGE: (mean: 33.6); Disease duration: (mean: 3.6 y); | GCTNPCM |